Market Research Report
North America Urology Laser Market (2019-2025)
|Published by||KBV Research||Product code||921187|
|Published||Content info||79 Pages
Delivery time: 1-2 business days
|North America Urology Laser Market (2019-2025)|
|Published: December 31, 2019||Content info: 79 Pages||
The North America Urology Laser Market would witness market growth of 4.93% CAGR during the forecast period (2019-2025).
Technological advances in urology laser equipment play a vital role in stimulating the market for laser urology. For example, urology device Lumenis provides MOSES technology that delivers technologically advanced holmium laser lithotripsy and Benign Prostatic Hyperplasia (BPH) treatments. As a result, growing technical advances in clinical application treatment are boosting the region's overall growth.
The laser portfolio and its use in urological applications have been extended by technological developments in lasers and minimally invasive surgeries. In fact, increased access to these resources around the globe has resulted in rapid urology adoption. Laser use has made the urological surgeries an age-old approach. Laser-implied urology treatments have been shown to result in fewer complications after the procedure, decreased burning effects, and hemostasis throughout the procedure.
This is anticipated to drive globe-wide adoption. Increasing demand for minimally invasive surgery is also likely to inspire urologists to adopt lasers for several urological procedures. Nonetheless, in the near future, high costs of laser systems and consumables such as fibers would possibly hamper the market for urology lasers. It is expected that the introduction of alternative techniques like an external lithotripsy shock wave to treat urinary calculi would deter potential customers from opting for urology laser.
Based on Laser Type, the market is segmented into Holmium Laser System, Thulium laser system, Diode Laser System and Other Laser Type. Based on Application, the market is segmented into Benign Prostatic Hyperplasia (BPH), Urolithiasis, Non-Muscle-Invasive Bladder Cancer (NMIBC) and Other Application. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Olympus Corporation, Johnson and Johnson (Ethicon, Inc.), Stryker Corporation, Boston Scientific Corporation, Richard Wolf GmbH, Cook Medical, Inc. (Cook Group), Karl Storz SE & Co. KG, Lumenis Ltd. (XIO Group), Allengers Medical Systems Limited, and Becton, Dickinson and Company